I haven't fully digested this article, yet, but it does bear on the subject of costs and cost containment in the ACA.
Conservatives love to apply "cost-benefit analysis" to government programs--except in health care. In fact, working with drug companies and warning of "death panels," they slipped language into Obamacare banning cost-effectiveness research. Here's how that happened, and why it can't stand.
...The stunning inefficiency of the U.S. health care system as a whole is now beyond dispute. To see the magnitude of aggregate waste, one only has to look at the gross disparities in how medicine is practiced in different parts of the country and with what results.
The best-known work in this area comes from the Dartmouth Atlas Project. For more than a decade, researchers there have systematically reviewed the medical records of deceased Medicare patients nationwide, including those who suffered from specific chronic conditions during their last two years of life. And by doing so, the researchers have uncovered striking anomalies that point to vast inefficiencies.
...Yet while we know the system as a whole is grossly inefficient, it remains easy for those responsible for the waste to escape detection, let alone accountability. The biggest single reason is that, due to the insistence of conservatives allied with drug manufacturers and medical device makers, the federal government is not allowed to consider the cost-effectiveness of different treatments in deciding how to invest health care dollars.
The article goes on to describe the political infighting that prevented any real assessment of the inefficiencies of the health care system ... including the "death panel" fairy tale.
On first read, it kind of reminds me of the Medicare drug coverage legislation that explicitly forbids Medicare from bargaining over prices.
It never fails to amaze me ... forbid the government from doing it's job, then complain because the job is not getting done.